Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.

Phase 4CompletedNCT00665483

Allergopharma GmbH & Co. KG

Overview

Multicenter Skin Prick Test

Study Type

INTERVENTIONAL

Conditions

Type I Allergy

Interventions

Skin Prick TestOTHER

Skin Prick Test

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * anamnesis referring to suspicion of an IgE-mediated allergy * positive Skin Prick Test in the medical history to at least one of the investigational allergens with an existing anamnesis Exclusion Criteria: * serious chronic diseases * Other perennial allergies

Locations (1)

Klinikum Darmstadt

Darmstadt, Hesse, Germany

Outcomes

Primary Outcomes

Optimal trade-off between sensitivity and specificity

Time frame: December 2007 - December 2008

Secondary Outcomes

Evaluation of the documentation of adverse events

Time frame: January - December 2008

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.